002010:SZSETransfar Zhilian Co., Ltd. Analysis
Data as of 2026-09-08 - not real-time
CN¥4.77
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Transfar Zhilian Co., Ltd. is priced at ¥4.77, and its moving averages give no clean directional read — the structure is neutral. It has gained 4.1% over the past 30 days. With RSI at 54.2 the momentum picture is neutral, alongside a bullish MACD signal. Price has been bracketed by support at ¥4.56 and resistance at ¥4.89.
Multiples put this in fair territory at a P/E of 25.1. The average analyst target implies 11.1% above today's level. Revenue is contracting at 36.5% on a 2.5% profit margin. The 3.20% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 24.2%, a beta of 0.34 and a maximum drawdown of 37.4%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 4 out of 10.
Multiples put this in fair territory at a P/E of 25.1. The average analyst target implies 11.1% above today's level. Revenue is contracting at 36.5% on a 2.5% profit margin. The 3.20% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 24.2%, a beta of 0.34 and a maximum drawdown of 37.4%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 4 out of 10.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading below the 200-day average of 5.57
- MACD momentum is positive
- Maximum drawdown of 37.4%
Medium Term
1–3 yearsNeutral
Model confidence: 4/10
Key Factors
- Trading below the 200-day average of 5.57
- Analyst targets imply +11.1% versus the current price
- MACD momentum is positive
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Analyst targets imply +11.1% versus the current price
- Revenue contracting at -36.5%
- P/E ratio of 25.1
Key Metrics & Analysis
Financial Health
Revenue Growth-36.50%
Profit Margin2.55%
P/E Ratio25.1
ROE3.05%
ROA1.60%
Debt/Equity72.38
P/B Ratio0.7
Op. Cash FlowCN¥773.9M
Free Cash FlowCN¥328.9M
Technical Analysis
TrendNeutral
RSI54.2
SupportCN¥4.56
ResistanceCN¥4.89
MA 20CN¥4.70
MA 50CN¥4.68
MA 200CN¥5.57
MACDBullish
VolumeIncreasing
Fear & Greed Index93.98
Valuation
Target PriceCN¥5.30
Upside/Downside11.11%
GradeFair
TypeValue
Dividend Yield3.20%
Risk Assessment
Beta0.34
Volatility24.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.